myChoice CDx
Total Payments
$425,475
Transactions
1,134
Doctors
698
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $88,828 | 420 | 255 |
| 2021 | $331,277 | 704 | 493 |
| 2020 | $5,316 | 6 | 4 |
| 2019 | $53.81 | 4 | 4 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $128,450 | 1 | 30.2% |
| Consulting Fee | $126,413 | 102 | 29.7% |
| Honoraria | $87,981 | 73 | 20.7% |
| Food and Beverage | $40,504 | 868 | 9.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $26,175 | 13 | 6.2% |
| Travel and Lodging | $13,786 | 75 | 3.2% |
| Space rental or facility fees (teaching hospital only) | $2,000 | 1 | 0.5% |
| Unspecified | $165.00 | 1 | 0.0% |
Payments by Type
General
$425,310
1,133 transactions
Research
$165.00
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| EndoPredict Extended Endocrine Trial (EXET) | MYRIAD GENETIC LABORATORIES, INC. | $165.00 | 0 |
Top Doctors Receiving Payments for myChoice CDx
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Los Angeles, CA | $130,615 | 3 |
| , M.D | Gynecologic Oncology | Teaneck, NJ | $57,401 | 58 |
| , MD | Medical Oncology | Paris, TX | $39,033 | 35 |
| , MD | Gynecologic Oncology | Phoenix, AZ | $32,108 | 33 |
| , MD | Gynecologic Oncology | Pittsburgh, PA | $17,120 | 17 |
| , M.D | Hematology & Oncology | Houston, TX | $8,367 | 10 |
| , M.D | Gynecologic Oncology | San Antonio, TX | $7,842 | 12 |
| , M.D | Obstetrics & Gynecology | San Diego, CA | $6,007 | 9 |
| , MD | Gynecologic Oncology | Chicago, IL | $5,626 | 9 |
| , MD | Obstetrics & Gynecology | Fort Worth, TX | $5,387 | 7 |
| , M.D | Medical Oncology | Germantown, TN | $5,363 | 9 |
| , MD | Hematology & Oncology | Portland, OR | $5,128 | 9 |
| , D.O | Obstetrics & Gynecology | Kansas City, MO | $4,949 | 6 |
| , DO | Hematology & Oncology | Wynnewood, PA | $4,570 | 5 |
| , MD | Obstetrics & Gynecology | San Francisco, CA | $4,430 | 7 |
| , M.D | Gynecologic Oncology | Houston, TX | $4,200 | 3 |
| , MD | Obstetrics & Gynecology | Houston, TX | $4,200 | 3 |
| , M.D | Gynecologic Oncology | San Francisco, CA | $3,655 | 10 |
| , MD | Gynecologic Oncology | Nashville, TN | $2,800 | 2 |
| , MD | Specialist | Pittsburgh, PA | $2,800 | 2 |
| , M.D | Internal Medicine | Westwood, KS | $2,800 | 2 |
| , M.D | Specialist | Arlington, VA | $2,800 | 2 |
| , PA-C | Physician Assistant | Austin, TX | $2,491 | 8 |
| , FNP-BC | Family | Tyler, TX | $2,270 | 9 |
| , M.D | Gynecologic Oncology | Edinburg, TX | $1,913 | 4 |
Ad
Manufacturing Companies
- Myriad Genetic Laboratories, Inc. $425,310
- MYRIAD GENETIC LABORATORIES, INC. $165.00
Product Information
- Type Device
- Total Payments $425,475
- Total Doctors 698
- Transactions 1,134
About myChoice CDx
myChoice CDx is a device associated with $425,475 in payments to 698 healthcare providers, recorded across 1,134 transactions in the CMS Open Payments database. The primary manufacturer is Myriad Genetic Laboratories, Inc..
Payment data is available from 2019 to 2022. In 2022, $88,828 was paid across 420 transactions to 255 doctors.
The most common payment nature for myChoice CDx is "Royalty or License" ($128,450, 30.2% of total).
myChoice CDx is associated with 1 research study, including "EndoPredict Extended Endocrine Trial (EXET)" ($165.00).